Oncolytic viruses are still a fairly nascent area of cancer research. No such treatments are yet available in the West despite Chinese biotech Shanghai Sunway winning the world's first approval for an oncolytic virus in 2005. America's Amgen hopes to become the first company to win approval for an oncolytic virus in the West after submitting its therapy to EU medicine regulators in September.